224 related articles for article (PubMed ID: 30986855)
1. PIP5k1β controls bone homeostasis through modulating both osteoclast and osteoblast differentiation.
Zhao X; Cui P; Hu G; Wang C; Jiang L; Zhao J; Xu J; Zhang X
J Mol Cell Biol; 2020 Jan; 12(1):55-70. PubMed ID: 30986855
[TBL] [Abstract][Full Text] [Related]
2. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
3. The role of small leucine zipper protein in osteoclastogenesis and its involvement in bone remodeling.
Kim S; Park S; Kang M; Ko J
Biochim Biophys Acta Mol Cell Res; 2020 Nov; 1867(11):118827. PubMed ID: 32822727
[TBL] [Abstract][Full Text] [Related]
4. Acvr1 deletion in osteoblasts impaired mandibular bone mass through compromised osteoblast differentiation and enhanced sRANKL-induced osteoclastogenesis.
Hu Y; Hao X; Liu C; Ren C; Wang S; Yan G; Meng Y; Mishina Y; Shi C; Sun H
J Cell Physiol; 2021 Jun; 236(6):4580-4591. PubMed ID: 33251612
[TBL] [Abstract][Full Text] [Related]
5. mmu-miR-185 regulates osteoclasts differentiation and migration by targeting Btk.
He D; Jiao Y; Xu J; Luo J; Cui Y; Han X; Zhao H
J Gene Med; 2024 May; 26(5):e3687. PubMed ID: 38690623
[TBL] [Abstract][Full Text] [Related]
6. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
[TBL] [Abstract][Full Text] [Related]
7. The L-type amino acid transporter LAT1 inhibits osteoclastogenesis and maintains bone homeostasis through the mTORC1 pathway.
Ozaki K; Yamada T; Horie T; Ishizaki A; Hiraiwa M; Iezaki T; Park G; Fukasawa K; Kamada H; Tokumura K; Motono M; Kaneda K; Ogawa K; Ochi H; Sato S; Kobayashi Y; Shi YB; Taylor PM; Hinoi E
Sci Signal; 2019 Jul; 12(589):. PubMed ID: 31289211
[TBL] [Abstract][Full Text] [Related]
8. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
9. Stimuli and Relevant Signaling Cascades for NFATc1 in Bone Cell Homeostasis: Friend or Foe?
Zhang Z; Wen H; Yang X; Zhang K; He B; Zhang X; Kong L
Curr Stem Cell Res Ther; 2019; 14(3):239-243. PubMed ID: 30516111
[TBL] [Abstract][Full Text] [Related]
10. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
[TBL] [Abstract][Full Text] [Related]
11. Maintenance of Bone Homeostasis by DLL1-Mediated Notch Signaling.
Muguruma Y; Hozumi K; Warita H; Yahata T; Uno T; Ito M; Ando K
J Cell Physiol; 2017 Sep; 232(9):2569-2580. PubMed ID: 27735989
[TBL] [Abstract][Full Text] [Related]
12. Bifunctional Role of CrkL during Bone Remodeling.
Kim JH; Kim K; Kim I; Seong S; Kook H; Kim KK; Koh JT; Kim N
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209812
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E plays crucial roles in maintaining bone mass by promoting osteoblast differentiation via ERK1/2 pathway and by suppressing osteoclast differentiation via c-Fos, NFATc1, and NF-κB pathway.
Noguchi T; Ebina K; Hirao M; Otsuru S; Guess AJ; Kawase R; Ohama T; Yamashita S; Etani Y; Okamura G; Yoshikawa H
Biochem Biophys Res Commun; 2018 Sep; 503(2):644-650. PubMed ID: 29906458
[TBL] [Abstract][Full Text] [Related]
14. STAT3 controls osteoclast differentiation and bone homeostasis by regulating NFATc1 transcription.
Yang Y; Chung MR; Zhou S; Gong X; Xu H; Hong Y; Jin A; Huang X; Zou W; Dai Q; Jiang L
J Biol Chem; 2019 Oct; 294(42):15395-15407. PubMed ID: 31462535
[TBL] [Abstract][Full Text] [Related]
15. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.
Han SY; Lee KH; Kim YK
Int J Mol Med; 2018 Jul; 42(1):331-345. PubMed ID: 29620250
[TBL] [Abstract][Full Text] [Related]
16. DDR2 (discoidin domain receptor 2) suppresses osteoclastogenesis and is a potential therapeutic target in osteoporosis.
Zhang Y; Su J; Wu S; Teng Y; Yin Z; Guo Y; Li J; Li K; Yao L; Li X
Sci Signal; 2015 Mar; 8(369):ra31. PubMed ID: 25805889
[TBL] [Abstract][Full Text] [Related]
17. Ameloblastin attenuates RANKL-mediated osteoclastogenesis by suppressing activation of nuclear factor of activated T-cell cytoplasmic 1 (NFATc1).
Chaweewannakorn W; Ariyoshi W; Okinaga T; Fujita Y; Maki K; Nishihara T
J Cell Physiol; 2019 Feb; 234(2):1745-1757. PubMed ID: 30105896
[TBL] [Abstract][Full Text] [Related]
18. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
[TBL] [Abstract][Full Text] [Related]
19. Streptococcus gordonii induces bone resorption by increasing osteoclast differentiation and reducing osteoblast differentiation.
Park OJ; Kim J; Kim HY; Kwon Y; Yun CH; Han SH
Microb Pathog; 2019 Jan; 126():218-223. PubMed ID: 30414445
[TBL] [Abstract][Full Text] [Related]
20. Dual Role of Cyanidin-3-glucoside on the Differentiation of Bone Cells.
Park KH; Gu DR; So HS; Kim KJ; Lee SH
J Dent Res; 2015 Dec; 94(12):1676-83. PubMed ID: 26350961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]